Anjali Singh

Alkem Q4 profit falls 23% on one-off hit; sees strong FY27 pipeline

The drugmaker said strong domestic branded generics and international business growth helped drive record EBITDA performance in FY26

Sanofi unveils AI-powered platform for early rare disease detection

Sanofi's AI-powered AccelRare platform aims to help doctors identify rare diseases faster and improve referrals to specialist treatment centres in India

Sun Pharma's Unloxcyt posts 50% response rate in skin cancer study

Updated data from the CK-301-101 trial showed durable responses and manageable safety profile in patients with locally advanced cutaneous squamous cell carcinoma

JK Tyre Q4FY26 profit nearly doubles; plans ₹4,980 crore expansion

The tyre maker posted strong fourth-quarter earnings driven by robust demand and announced a phased capacity expansion amid rising domestic and export opportunities

Tyre, auto-component firms hint at fresh price hikes amid input cost rise

Tyre and auto-component makers raise prices as raw material and energy inflation erodes margins

High-value clinical research marks gradual shift to India: Parexel

Parexel says India is evolving into a strategic innovation and clinical research hub as global pharmaceutical firms shift high-value functions and decision-making roles

Sun Pharma's US generics business remains under pressure in FY26

Innovative medicines business crosses $1 billion milestone as company expands specialty pipeline and bets on Organon acquisition

Dr Reddy's unveils oral diabetes drug Obeda for type 2 patients in India

The once-daily prescription tablet for type 2 diabetes received CDSCO approval after a Phase III trial showed comparable efficacy and safety to the innovator drug

Eris Lifesciences Q4 profit jumps three-fold to ₹281.6 cr; shares surge 11%

The pharmaceutical company reported robust growth in domestic formulations and insulin franchise performance, while maintaining a strong EBITDA margin of 37 per cent

ICRA projects 3-5% growth in domestic two-wheeler volumes for FY27

Credit rating agency says domestic two-wheeler wholesale volumes may grow 3-5% in FY27, while exports and electric vehicle demand continue to support the industry

HAB Pharma targets ₹3,000 crore revenue by 2030 after merger deal

HAB Pharmaceuticals aims to scale operations and expand globally after merging with Signature Phytochemical Industries through a slump sale deal

Nephrocare Health Services profit up 75% in FY26 on strong dialysis demand

NephroPlus posted a 74.6% jump in FY26 profit as higher dialysis volumes and rapid international expansion boosted revenue and margins

Biosimilars could surpass generics in US mkt by early 2030s: Dr Reddy's CEO

Dr Reddy's CEO Erez Israeli says semaglutide, biosimilars and oncology will drive the company's next growth phase as it expands beyond traditional generics globally

Cancer care expands beyond metros as providers bet on tier-2, tier-3 India

Hospitals, diagnostics firms, and support groups are expanding cancer care into tier-2 and tier-3 cities as demand, screening and awareness rise beyond large metros

RPG Group on PM Modi's call for restraint: WFH, cleaner mobility

Harsh Goenka says the conglomerate is expanding remote work, limiting travel and accelerating electric mobility adoption amid West Asia tensions

India's electric bus push gains speed amid strong market recovery: Report

KPMG report says government schemes, rising urban mobility demand and improving economics are accelerating growth in India's electric bus market

Cipla Q4 profit plunges 55% to ₹554.6 cr amid US drag, higher R&D spend

Drugmaker cites lower contribution from key US products, higher R&D investments and rising operating costs as Q4 FY26 profit declines sharply

Asia Healthcare Holdings appoints three independent directors to board

GIC and TPG-backed Asia Healthcare Holdings has inducted three independent directors as it expands its specialty healthcare network across India

PM Modi's EV push lifts industry confidence, but policy gaps persist

India's EV industry sees stronger momentum after Prime Minister Narendra Modi renewed his push for electric mobility amid rising sales and infrastructure growth

West Asia tensions begin disrupting India's auto supply chain, margins

Bajaj Auto, Hero MotoCorp and Ather Energy flag rising commodity prices, freight costs and supply-chain disruptions as geopolitical tensions weigh on demand and margins